StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Sun Pharmaceutical Industries Limited
NSE:SUNPHARMA.NS
Sector
Location
Market Cap
USD 46.79 B
Share Price
USD 19.48
Avg Daily Volume
2,615,631
Change (1 day)
0.27%
Change (1 year)
1.85%
Change (YTD)
-11.58%
Sun Pharmaceutical Industries Limited EBITDA for the year ending March 31, 2025: USD 1.77 B
Sun Pharmaceutical Industries Limited EBITDA is USD 1.77 B for the year ending March 31, 2025, a 6.42% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Sun Pharmaceutical Industries Limited EBITDA for the year ending March 31, 2024 was USD 1.66 B, a 12.82% change year over year.
-
Sun Pharmaceutical Industries Limited EBITDA for the year ending March 31, 2023 was USD 1.47 B, a 66.64% change year over year.
-
Sun Pharmaceutical Industries Limited EBITDA for the year ending March 31, 2022 was USD 882.34 M, a 29.25% change year over year.
-
Sun Pharmaceutical Industries Limited EBITDA for the year ending March 31, 2021 was USD 682.66 M, a -29.65% change year over year.
Competitors
Eli Lilly and Company
USD 798.89
LLY
+22.45
2.89%
Johnson & Johnson
USD 169.10
JNJ
+1.17
0.70%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
McKesson Corporation
USD 714.00
MCK
+4.53
0.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Elevance Health Inc.
USD 296.60
ELV
+14.88
5.28%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
Cencora, Inc.
USD 293.44
COR
+0.47
0.16%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.97
600276.SS
-0.01
-0.09%
Lonza Group AG
USD 718.59
LONN.SW
+18.96
2.71%
Takeda Pharmaceutical Company Limited
USD 29.83
4502.T
+0.18
0.60%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Eli Lilly and Company
USD 798.89
LLY
+22.45
2.89%
Johnson & Johnson
USD 169.10
JNJ
+1.17
0.70%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
McKesson Corporation
USD 714.00
MCK
+4.53
0.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Elevance Health Inc.
USD 296.60
ELV
+14.88
5.28%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
Cencora, Inc.
USD 293.44
COR
+0.47
0.16%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.97
600276.SS
-0.01
-0.09%
Lonza Group AG
USD 718.59
LONN.SW
+18.96
2.71%
Takeda Pharmaceutical Company Limited
USD 29.83
4502.T
+0.18
0.60%